Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trialFeng Wang, Rui‐Hua Xu, Ying Jin et al.|Nature Medicine|2024Cited by 162
Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significanceLin Mei, Ming‐Yuan Chen, Yu‐Long Xie et al.|Nature Communications|2023Cited by 65
A phase I study of toripalimab, an anti‐PD‐1 antibody, in patients with refractory malignant solid tumorsXiaoli Wei, Rui‐Hua Xu, Feng‐Hua Wang et al.|Cancer Communications|2020Cited by 54
Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinomaGuozhen Yang, Xu Zhang, Xiaodong Su et al.|Annals of Translational Medicine|2021Cited by 54